NCT02453984View on ClinicalTrials.gov

MPDL3280A-imaging-IST-UMCG

NAActive, not recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 24, 2016

Primary Completion Date

November 23, 2020

Study Completion Date

June 30, 2024

Conditions
Locally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 Expression
Interventions
OTHER

89Zr-MPDL-3280A-PET scans

89Zr-MPDL3280A tracer injection and 89Zr-MPDL-3280A-PET scans

Trial Locations (1)

9713 GZ

University Medical Center Groningen, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT02453984 - MPDL3280A-imaging-IST-UMCG | Biotech Hunter | Biotech Hunter